Frontiers SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19)

$ 11.00

4.6 (145) In stock

Severe COVID-19 can be associated with a prothrombotic state, increasing risk of morbidity and mortality. The SARS-CoV-2 spike glycoprotein is purported to d

48 Javier Lopez Jr Stock Photos, High-Res Pictures, and Images

Frontiers Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern

Immunogenicity and protective efficacy of SARS-CoV-2 mRNA vaccine encoding secreted non-stabilized spike in female mice

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against

Frontiers Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis

Generation of potent cellular and humoral immunity against SARS

Current Update on Severe Acute Respiratory Syndrome Coronavirus 2

Generation of potent cellular and humoral immunity against SARS

A critical overview of current progress for COVID-19: development